Key features and details
- Rabbit polyclonal to Prostate Specific Antigen - Catalytic domain
- Suitable for: WB
- Reacts with: Human
- Isotype: IgG
Product nameAnti-Prostate Specific Antigen antibody - Catalytic domain
See all Prostate Specific Antigen primary antibodies
DescriptionRabbit polyclonal to Prostate Specific Antigen - Catalytic domain
SpecificityThis antibody is specific for Kallikrein 3, it does not react with the other Kallikreins (1,2,4-15).
Tested applicationsSuitable for: WBmore details
Species reactivityReacts with: Human
Synthetic peptide based on the catalytic domain of human Kallikrein 3. (Peptide available as ab43085.)
Storage instructionsShipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
Storage bufferPreservative: 0.05% Sodium azide
Constituent: 50% Glycerol
Concentration information loading...
PurityImmunogen affinity purified
Our Abpromise guarantee covers the use of ab40949 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|WB||1/1000. Predicted molecular weight: 29 kDa. 1/1000 when using colorimetric substrates such as BCIP/NBT and 1/5000 for chemiluminescent substrates. Predicted molecular weight: 29 kDa. Dilution optimised using Chromogenic detection.|
FunctionHydrolyzes semenogelin-1 thus leading to the liquefaction of the seminal coagulum.
Sequence similaritiesBelongs to the peptidase S1 family. Kallikrein subfamily.
Contains 1 peptidase S1 domain.
- Information by UniProt
- antigen, prostate-specific antibody
- APS antibody
- Gamma seminoprotein antibody
All lanes : Anti-Prostate Specific Antigen antibody - Catalytic domain (ab40949) at 1/1000 dilution
Lane 1 : Human Kallikrein 3 at 0.05 µg
Lane 2 : Human Kallikrein 3 at 0.01 µg
Lane 3 : Human Kallikrein 3 at 0.001 µg
Predicted band size: 29 kDa
Observed band size: 33 kDa why is the actual band size different from the predicted?
ab40949 has not yet been referenced specifically in any publications.